Australia has a tough, newly validated weapon to go after multinational companies it sees as tax dodgers—and US technology and pharmaceutical companies may take a hit.
Michael Rapoport is a Senior Reporter for Accounting Today, with his work also appearing in Bloomberg Law. He specializes in reporting on tax regulations, court cases, and other developments in the accounting and finance industry. With his expertise in tax law and his ability to break down complex concepts, Michael provides valuable insights and analysis to his readers.